Sagimet Biosciences Growth Metrics (2023-2024) | SGMT

Growth Metrics Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024
Growth Ratios
Assets Growth (1y) 779.24%69.81%
Assets (QoQ) 378.77%-6.03%101.13%-2.83%-7.54%
Cash & Equivalents Growth (1y) 418.47%-24.38%
Cash & Equivalents (QoQ) 450.26%-26.22%135.27%-45.72%-19.74%
Cash from Investing Activities Growth (1y) -84.54%-687.16%
Cash from Investing Activities (QoQ) -34.02%115.29%-2,605.23%100.83%
Cash from Operations Growth (1y) 12.37%1.50%-404.49%
Cash from Operations (QoQ) 19.25%32.19%-82.60%12.35%9.25%-247.34%
EBIT (QoQ) -27.03%
EBT (QoQ) -28.24%
Enterprise Value Growth (1y) -209.20%-163.65%
Enterprise Value (QoQ) 637.40%-70.64%-171.00%-176.04%-10.62%
EPS (Basic) (QoQ) 260.00%
EPS (Weighted Average and Diluted) (QoQ) 260.00%
Free Cash Flow Growth (1y) 12.37%1.50%-404.49%
Free Cash Flow (QoQ) 19.25%32.19%-82.60%12.35%9.25%-247.34%
Net Cash Flow Growth (1y) 734.47%-1,409.85%-122.73%
Net Cash Flow (QoQ) -49.34%1,250.63%-132.04%480.62%-179.52%76.56%
Net Income (QoQ) -28.24%
Net Income towards Common Stockholders (QoQ) -28.24%
Operating Income (QoQ) -27.03%
Profit After Tax (QoQ) -28.30%
Share-based Compensation Growth (1y) -1.04%37.09%-16.66%
Share-based Compensation (QoQ) 37.81%75.50%-29.33%-42.11%90.91%6.69%
Shareholder's Equity Growth (1y) 192.38%74.39%
Shareholder's Equity (QoQ) 149.33%-6.96%108.66%-3.54%-6.88%